Parkman Healthcare Partners LLC Forma Therapeutics Holdings, Inc. Transaction History

Parkman Healthcare Partners LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$5.1 - $10.0 $233,105 - $457,070	-45,707 Reduced 36.77%	78,603 $542,000
Q1 2022 May 13, 2022	BUY	$8.34 - $14.69 $202,745 - $357,113	24,310 Added 24.31%	124,310 $1.16 Million
Q4 2021 Feb 11, 2022	BUY	$13.6 - $24.89 $1.36 Million - $2.49 Million	100,000 New	100,000 $1.42 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.